RETRA hydrobromide
RETRA (hydrobromide) is a mutant p53-dependent activator of p73 that can inhibit cancer cells carrying mutant p53. RETRA (hydrobromide) increases the expression level of p73, induces transcriptional activation of several common to transcriptional targets p53 and p73, which leads to mutant p53- and p73-dependent inhibition of tumor growth, reduction of colony formation and induction of effector caspases.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1035875-01-4
- Fòrmula: C11H12BrNO3S2
- Peso molecular:350.25
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Chemical Information
-
No. CAS 1035875-01-4
-
Peso molecular 350.25
-
Fòrmula C11H12BrNO3S2
-
SMILES
O=C(CSC1=NCCS1)C2=CC=C(C(O)=C2)O.Br
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)